Rania M Mohamed, Bikash Panthi, Beatriz E Adrada, Medine Boge, Rosalind P Candelaria, Huiqin Chen, Mary S Guirguis, Kelly K Hunt, Lei Huo, Ken-Pin Hwang, Anil Korkut, Jennifer K Litton, Tanya W Moseley, Sanaz Pashapoor, Miral M Patel, Brandy Reed, Marion E Scoggins, Jong Bum Son, Alastair Thompson, Debu Tripathy, Vicente Valero, Peng Wei, Jason White, Gary J Whitman, Zhan Xu, Wei Yang, Clinton Yam, Jingfei Ma, Gaiane M Rauch
Triple-negative breast cancer (TNBC) is often treated with neoadjuvant systemic therapy (NAST). We investigated if radiomic models based on multiparametric Magnetic Resonance Imaging (MRI) obtained early during NAST predict pathologic complete response (pCR). We included 163 patients with stage I-III TNBC with multiparametric MRI at baseline and after 2 (C2) and 4 cycles of NAST. Seventy-eight patients (48%) had pCR, and 85 (52%) had non-pCR. Thirty-six multivariate models combining radiomic features from dynamic contrast-enhanced MRI and diffusion-weighted imaging had an area under the receiver operating characteristics curve (AUC) > 0.7. The top-performing model combined 35 radiomic features of relative difference between C2 and baseline; had an AUC = 0.905 in the training and AUC = 0.802 in the testing set. There was high inter-reader agreement and very similar AUC values of the pCR prediction models for the 2 readers. Our data supports multiparametric MRI-based radiomic models for early prediction of NAST response in TNBC.
Oncotarget. 2017 Jan 3;8(1):1913-1924
[PMID:
27765921]
Radiology. 2018 Dec;289(3):618-627
[PMID:
30179110]
Breast Cancer Res. 2016 Jul 22;18(1):76
[PMID:
27449059]
J Magn Reson Imaging. 2018 Feb;47(2):301-315
[PMID:
28639300]
Cancers (Basel). 2023 Feb 06;15(4):
[PMID:
36831368]
Radiology. 2017 Mar;282(3):665-675
[PMID:
27700229]
Sci Rep. 2015 Dec 07;5:17787
[PMID:
26639025]
J Magn Reson Imaging. 2016 Nov;44(5):1107-1115
[PMID:
27080586]
Eur J Cancer. 2012 Mar;48(4):441-6
[PMID:
22257792]
J Magn Reson Imaging. 2022 Dec;56(6):1901-1909
[PMID:
35499264]
Cancer. 2016 Mar 1;122(5):748-57
[PMID:
26619259]
Clin Cancer Res. 2019 Jun 15;25(12):3538-3547
[PMID:
30842125]
N Engl J Med. 2020 Feb 27;382(9):810-821
[PMID:
32101663]
J Clin Oncol. 2008 Mar 10;26(8):1275-81
[PMID:
18250347]
Invest Radiol. 2015 Apr;50(4):195-204
[PMID:
25360603]
Radiol Imaging Cancer. 2023 Jul;5(4):e230009
[PMID:
37505106]
J Clin Oncol. 2013 Nov 1;31(31):3997-4013
[PMID:
24101045]
J Clin Oncol. 2012 May 20;30(15):1796-804
[PMID:
22508812]
Cancer Med. 2014 Jun;3(3):462-71
[PMID:
24573979]
Radiology. 2015 Aug;276(2):360-70
[PMID:
25751227]
Breast Cancer Res. 2015 May 19;17:67
[PMID:
25986460]
J Magn Reson Imaging. 2024 Jan 31;:
[PMID:
38294179]
Clin Transl Oncol. 2020 Jan;22(1):50-59
[PMID:
30977048]
J Clin Oncol. 2011 Feb 20;29(6):660-6
[PMID:
21220595]
Eur Radiol. 2019 May;29(5):2535-2544
[PMID:
30402704]
Radiology. 2014 Jul;272(1):91-9
[PMID:
24620909]
Eur Radiol. 2020 Mar;30(3):1436-1450
[PMID:
31786616]
N Engl J Med. 2010 Nov 11;363(20):1938-48
[PMID:
21067385]
Sci Rep. 2023 Jan 20;13(1):1171
[PMID:
36670144]
Clin Cancer Res. 2019 Mar 15;25(6):1756-1765
[PMID:
30647080]
Invest New Drugs. 2023 Jun;41(3):391-401
[PMID:
37043123]
J Comput Assist Tomogr. 2020 Mar/Apr;44(2):275-283
[PMID:
32004189]
Am J Transl Res. 2021 May 15;13(5):4422-4436
[PMID:
34150024]
Breast Cancer Res Treat. 2023 Jun;199(3):457-469
[PMID:
37061619]
Radiology. 2016 Nov;281(2):382-391
[PMID:
27144536]
Chin J Cancer Res. 2018 Aug;30(4):432-438
[PMID:
30210223]
Br J Radiol. 2020 Nov 01;93(1115):20200287
[PMID:
32822542]
Humans
Triple Negative Breast Neoplasms
Female
Neoadjuvant Therapy
Middle Aged
Multiparametric Magnetic Resonance Imaging
Adult
Aged
Treatment Outcome
ROC Curve
Magnetic Resonance Imaging
Radiomics